Finance

Lists
Why is ALZCUR down 5,51%?
Dive Deeper
ALZCUR:STO
AlzeCure Pharma AB
SEK 6,86
-5,51%
(-0,40) 1D
2 Okt., 17:29:55 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ALZCUR...
Open
SEK 7,28
High
SEK 7,34
Low
SEK 6,86
Mkt. cap
945,98 m
Avg. vol.
433,16 k
Volume
242,98 k
P/E ratio
29,28
52-wk high
SEK 8,68
52-wk low
SEK 1,14
EPS
SEK 0,23
Shares outstanding
137,90 m
No. of employees
10
Open
SEK 7,28
High
SEK 7,34
Low
SEK 6,86
Mkt. cap
945,98 m
Avg. vol.
433,16 k
Volume
242,98 k
P/E ratio
29,28
52-wk high
SEK 8,68
52-wk low
SEK 1,14
EPS
SEK 0,23
Shares outstanding
137,90 m
No. of employees
10
News stories
From web sources and news partners
About AlzeCure Pharma AB
CEOMartin Jönsson
Employees10
Founded2012
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
97,33 m
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,71 m
16,11 m
20,68 m
15,96 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,36 m
2,91 m
3,34 m
4,42 m
Operating expense
10,05 m
18,05 m
21,77 m
17,09 m
Total operating expenses
10,05 m
18,05 m
21,77 m
17,09 m
Operating income
-10,05 m
-18,05 m
-21,77 m
80,23 m
Other non operating income
-
-
-
-
EBT including unusual items
-10,03 m
-17,75 m
-21,70 m
80,18 m
EBT excluding unusual items
-10,03 m
-17,75 m
-21,70 m
80,18 m
Income tax expense
-4,00 k
-4,00 k
-2,00 k
-1,00 k
Effective tax rate
0,04%
0,02%
0,01%
-
Other operating expenses
-15,00 k
-971,00 k
-2,25 m
-3,29 m
Net income
-10,02 m
-17,74 m
-21,70 m
80,18 m
Net profit margin
-
-
-
82,38%
Earnings per share
-
-
-
-
Interest and investment income
102,00 k
194,00 k
143,00 k
69,00 k
Interest expense
-66,00 k
-62,00 k
-58,00 k
-54,00 k
Net interest expenses
36,00 k
132,00 k
85,00 k
15,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,74 m
-17,75 m
-21,47 m
80,53 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme